Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313482880> ?p ?o ?g. }
- W4313482880 endingPage "118" @default.
- W4313482880 startingPage "103" @default.
- W4313482880 abstract "Multiple sclerosis (MS) treatment has received much attention, yet there is still no certain cure. We herein investigate the therapeutic effect of olean-12-en-28-ol, 3β-pentacosanoate (OPCA) on a preclinical model of MS. First, OPCA was synthesized semisynthetically and characterized. Then, the mice with MOG35-55-induced experimental autoimmune/allergic encephalomyelitis (EAE) were given OPCA along with a reference drug (FTY720). Biochemical, cellular, and molecular analyses were performed in serum and brain tissues to measure anti-inflammatory and neuroprotective responses. OPCA treatment protected EAE-induced changes in mouse brains maintaining blood-brain barrier integrity and preventing inflammation. Moreover, the protein and mRNA levels of MS-related genes such as HLD-DR1, CCL5, TNF-α, IL6, and TGFB1 were significantly reduced in OPCA-treated mouse brains. Notably, the expression of genes, including PLP, MBP, and MAG, involved in the development and structure of myelin was significantly elevated in OPCA-treated EAE. Furthermore, therapeutic OPCA effects included a substantial reduction in pro-inflammatory cytokines in the serum of treated EAE animals. Lastly, following OPCA treatment, the promoter regions for most inflammatory regulators were hypermethylated. These data support that OPCA is a valuable and appealing candidate for human MS treatment since OPCA not only normalizes the pro- and anti-inflammatory immunological bias but also stimulates remyelination in EAE." @default.
- W4313482880 created "2023-01-06" @default.
- W4313482880 creator A5012612442 @default.
- W4313482880 creator A5013712666 @default.
- W4313482880 creator A5014248621 @default.
- W4313482880 creator A5015437021 @default.
- W4313482880 creator A5016490827 @default.
- W4313482880 creator A5026567611 @default.
- W4313482880 creator A5084767970 @default.
- W4313482880 creator A5086303002 @default.
- W4313482880 date "2023-01-04" @default.
- W4313482880 modified "2023-10-18" @default.
- W4313482880 title "Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent" @default.
- W4313482880 cites W1538907359 @default.
- W4313482880 cites W1547957565 @default.
- W4313482880 cites W1653658786 @default.
- W4313482880 cites W1828576284 @default.
- W4313482880 cites W1871435570 @default.
- W4313482880 cites W1978790799 @default.
- W4313482880 cites W1986173197 @default.
- W4313482880 cites W2000631468 @default.
- W4313482880 cites W2012289895 @default.
- W4313482880 cites W2016097940 @default.
- W4313482880 cites W2018289835 @default.
- W4313482880 cites W2027775022 @default.
- W4313482880 cites W2032183897 @default.
- W4313482880 cites W2032743208 @default.
- W4313482880 cites W2064302386 @default.
- W4313482880 cites W2095897464 @default.
- W4313482880 cites W2100837269 @default.
- W4313482880 cites W2101356368 @default.
- W4313482880 cites W2102953188 @default.
- W4313482880 cites W2105206040 @default.
- W4313482880 cites W2107277218 @default.
- W4313482880 cites W2136670019 @default.
- W4313482880 cites W2137052537 @default.
- W4313482880 cites W2137455567 @default.
- W4313482880 cites W2142577589 @default.
- W4313482880 cites W2147760936 @default.
- W4313482880 cites W2160209245 @default.
- W4313482880 cites W2167842265 @default.
- W4313482880 cites W2171916359 @default.
- W4313482880 cites W2173525109 @default.
- W4313482880 cites W2192080449 @default.
- W4313482880 cites W2218091841 @default.
- W4313482880 cites W2292343120 @default.
- W4313482880 cites W2314198668 @default.
- W4313482880 cites W2403179475 @default.
- W4313482880 cites W2469466281 @default.
- W4313482880 cites W2470063080 @default.
- W4313482880 cites W2551613047 @default.
- W4313482880 cites W2552680227 @default.
- W4313482880 cites W2601146646 @default.
- W4313482880 cites W2618423461 @default.
- W4313482880 cites W2624289631 @default.
- W4313482880 cites W2749873811 @default.
- W4313482880 cites W2763147694 @default.
- W4313482880 cites W2767522821 @default.
- W4313482880 cites W2788166312 @default.
- W4313482880 cites W2801390089 @default.
- W4313482880 cites W2806912433 @default.
- W4313482880 cites W2886077162 @default.
- W4313482880 cites W2899153096 @default.
- W4313482880 cites W2899700042 @default.
- W4313482880 cites W2900569176 @default.
- W4313482880 cites W2909270098 @default.
- W4313482880 cites W2911658427 @default.
- W4313482880 cites W2939980218 @default.
- W4313482880 cites W2958070288 @default.
- W4313482880 cites W2971398822 @default.
- W4313482880 cites W2986659217 @default.
- W4313482880 cites W3007464906 @default.
- W4313482880 cites W3029462764 @default.
- W4313482880 cites W3042308502 @default.
- W4313482880 cites W3043273384 @default.
- W4313482880 cites W3048887029 @default.
- W4313482880 cites W3084964340 @default.
- W4313482880 cites W3087227326 @default.
- W4313482880 cites W3091747235 @default.
- W4313482880 cites W3092677152 @default.
- W4313482880 cites W3092998031 @default.
- W4313482880 cites W3093239695 @default.
- W4313482880 cites W3095773178 @default.
- W4313482880 cites W3099273656 @default.
- W4313482880 cites W3107789534 @default.
- W4313482880 cites W3128820871 @default.
- W4313482880 cites W4210250802 @default.
- W4313482880 cites W4211048507 @default.
- W4313482880 cites W4211254511 @default.
- W4313482880 cites W4214823027 @default.
- W4313482880 cites W4214939985 @default.
- W4313482880 cites W4243722521 @default.
- W4313482880 cites W4247537218 @default.
- W4313482880 cites W4250145052 @default.
- W4313482880 doi "https://doi.org/10.1021/acs.jnatprod.2c00798" @default.
- W4313482880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36598820" @default.
- W4313482880 hasPublicationYear "2023" @default.
- W4313482880 type Work @default.